Difference between revisions of "Kidney cancer staging"

Jump to navigation Jump to search
No change in size ,  18:56, 16 December 2015
Line 17: Line 17:
*Most cases are pT1a or pT3a.
*Most cases are pT1a or pT3a.
**pT2 is very rare and pT1b is uncommon for [[CCRCC]].<ref name=pmid16145369>{{Cite journal  | last1 = Bonsib | first1 = SM. | title = T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. | journal = J Urol | volume = 174 | issue = 4 Pt 1 | pages = 1199-202; discussion 1202 | month = Oct | year = 2005 | doi =  | PMID = 16145369 }}</ref>
**pT2 is very rare and pT1b is uncommon for [[CCRCC]].<ref name=pmid16145369>{{Cite journal  | last1 = Bonsib | first1 = SM. | title = T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. | journal = J Urol | volume = 174 | issue = 4 Pt 1 | pages = 1199-202; discussion 1202 | month = Oct | year = 2005 | doi =  | PMID = 16145369 }}</ref>
***3% of >7 cm CCRCCs are limited to the kidney.
***32% of 4.1-7.0 cm CCRCCs are limited to the kidney.
***32% of 4.1-7.0 cm CCRCCs are limited to the kidney.
***3% of >7 cm CCRCCs are limited to the kidney.


===Lymph node staging===
===Lymph node staging===
48,466

edits

Navigation menu